$86.50
0.690.80%
At Close: -
$86.50
00.00%
After Hours: Jul 19, 5:07 PM EDT
15 minutes delayed
Comments
Loading...
Edwards Lifesciences
EWNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Edwards Lifesciences (NYSE:EW) Stock, Analyst Ratings, Price Targets, Forecasts
Edwards Lifesciences Corp has a consensus price target of $94.95 based on the ratings of 25 analysts. The high is $110 issued by Truist Securities on July 16, 2024. The low is $57 issued by Wolfe Research on November 28, 2023. The 3 most-recent analyst ratings were released by Truist Securities, Citigroup, and Evercore ISI Group on July 16, 2024, July 10, 2024, and July 2, 2024, respectively. With an average price target of $102.33 between Truist Securities, Citigroup, and Evercore ISI Group, there's an implied 18.30% upside for Edwards Lifesciences Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Citigroup
Evercore ISI Group
Goldman Sachs
Deutsche Bank
1calculated from analyst ratings
Analyst Ratings for Edwards Lifesciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/16/2024 | Buy Now | 27.17% | Truist Securities | Richard Newitter | $105 → $110 | Maintains | Buy | Get Alert |
| 07/10/2024 | Buy Now | 22.54% | Citigroup | Joanne Wuensch | $105 → $106 | Maintains | Buy | Get Alert |
| 07/02/2024 | Buy Now | 5.2% | Evercore ISI Group | Vijay Kumar | $89 → $91 | Maintains | In-Line | Get Alert |
| 05/30/2024 | Buy Now | 23.7% | Goldman Sachs | David Roman | → $107 | Initiates | → Buy | Get Alert |
| 05/22/2024 | Buy Now | 21.39% | Citigroup | Joanne Wuensch | $98 → $105 | Upgrade | Neutral → Buy | Get Alert |
| 05/14/2024 | Buy Now | 19.08% | Deutsche Bank | Pito Chickering | $86 → $103 | Upgrade | Hold → Buy | Get Alert |
| 05/07/2024 | Buy Now | 16.76% | Barclays | Matt Miksic | $100 → $101 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | -1.73% | Canaccord Genuity | William Plovanic | $86 → $85 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 14.45% | Wells Fargo | Larry Biegelsen | $94 → $99 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 2.89% | Evercore ISI Group | Vijay Kumar | $92 → $89 | Maintains | In-Line | Get Alert |
| 04/26/2024 | Buy Now | -1.73% | Stifel | Rick Wise | $83 → $85 | Maintains | Hold | Get Alert |
| 04/26/2024 | Buy Now | 1.73% | Piper Sandler | Adam Maeder | $85 → $88 | Maintains | Neutral | Get Alert |
| 04/15/2024 | Buy Now | 16.76% | RBC Capital | Shagun Singh | $95 → $101 | Maintains | Outperform | Get Alert |
| 04/11/2024 | Buy Now | 21.39% | Mizuho | Anthony Petrone | $95 → $105 | Maintains | Buy | Get Alert |
| 04/04/2024 | Buy Now | 6.36% | Evercore ISI Group | Vijay Kumar | $86 → $92 | Maintains | In-Line | Get Alert |
| 04/03/2024 | Buy Now | 13.29% | Citigroup | Joanne Wuensch | $90 → $98 | Maintains | Neutral | Get Alert |
| 03/26/2024 | Buy Now | — | OTR Global | — | — | Upgrade | Mixed → Positive | Get Alert |
| 03/21/2024 | Buy Now | 19.08% | Morgan Stanley | Patrick Wood | $95 → $103 | Maintains | Overweight | Get Alert |
| 03/18/2024 | Buy Now | 15.61% | Oppenheimer | Suraj Kalia | $93 → $100 | Maintains | Outperform | Get Alert |
| 03/07/2024 | Buy Now | — | B of A Securities | Travis Steed | — | Upgrade | Neutral → Buy | Get Alert |
| 02/07/2024 | Buy Now | -4.05% | Stifel | Rick Wise | $70 → $83 | Maintains | Hold | Get Alert |
| 02/07/2024 | Buy Now | 9.83% | Morgan Stanley | Patrick Wood | $80 → $95 | Maintains | Overweight | Get Alert |
| 02/07/2024 | Buy Now | 9.83% | RBC Capital | Shagun Singh | $82 → $95 | Maintains | Outperform | Get Alert |
| 02/07/2024 | Buy Now | 9.83% | Mizuho | Anthony Petrone | $85 → $95 | Maintains | Buy | Get Alert |
| 02/02/2024 | Buy Now | 8.67% | Wells Fargo | Larry Biegelsen | → $94 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/12/2024 | Buy Now | -5.2% | RBC Capital | Shagun Singh | $80 → $82 | Maintains | Outperform | Get Alert |
| 01/04/2024 | Buy Now | -10.98% | Evercore ISI Group | Vijay Kumar | $80 → $77 | Downgrade | Outperform → In-Line | Get Alert |
| 12/22/2023 | Buy Now | -2.89% | Truist Securities | Richard Newitter | $78 → $84 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | -9.83% | Truist Securities | Richard Newitter | $76 → $78 | Maintains | Buy | Get Alert |
| 12/11/2023 | Buy Now | — | Citigroup | Joanne Wuensch | — | Downgrade | Buy → Neutral | Get Alert |
| 12/04/2023 | Buy Now | -7.51% | Morgan Stanley | Patrick Wood | $102 → $80 | Maintains | Overweight | Get Alert |
| 11/28/2023 | Buy Now | -34.1% | Wolfe Research | Mike Polark | → $57 | Downgrade | Peer Perform → Underperform | Get Alert |
| 10/26/2023 | Buy Now | -19.08% | Stifel | Rick Wise | $87 → $70 | Maintains | Hold | Get Alert |
| 10/26/2023 | Buy Now | -1.73% | Mizuho | Anthony Petrone | $90 → $85 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -12.14% | Truist Securities | Richard Newitter | $83 → $76 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -5.2% | RBC Capital | Shagun Singh | $86 → $82 | Maintains | Outperform | Get Alert |
| 10/26/2023 | Buy Now | -21.39% | Piper Sandler | Adam Maeder | $83 → $68 | Maintains | Neutral | Get Alert |
| 10/26/2023 | Buy Now | -1.73% | Citigroup | Joanne Wuensch | $94 → $85 | Maintains | Buy | Get Alert |
| 10/26/2023 | Buy Now | -13.29% | Wells Fargo | Larry Biegelsen | $88 → $75 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | Buy Now | -13.29% | Leerink Partners | Mike Kratky | → $75 | Initiates | → Market Perform | Get Alert |
| 10/02/2023 | Buy Now | 8.67% | Citigroup | Joanne Wuensch | $110 → $94 | Maintains | Buy | Get Alert |
| 09/26/2023 | Buy Now | 4.05% | Oppenheimer | Suraj Kalia | → $90 | Upgrade | Perform → Outperform | Get Alert |
| 09/08/2023 | Buy Now | -4.05% | Piper Sandler | Adam Maeder | $88 → $83 | Maintains | Neutral | Get Alert |
| 08/17/2023 | Buy Now | 10.98% | RBC Capital | Shagun Singh | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 08/01/2023 | Buy Now | 10.98% | RBC Capital | Shagun Singh | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | 17.92% | Morgan Stanley | Patrick Wood | $102 → $102 | Reiterates | Overweight → Overweight | Get Alert |
| 07/27/2023 | Buy Now | 10.98% | RBC Capital | Shagun Singh | → $96 | Reiterates | Outperform → Outperform | Get Alert |
| 07/27/2023 | Buy Now | 15.61% | JP Morgan | Robbie Marcus | $95 → $100 | Maintains | Overweight | Get Alert |
| 07/25/2023 | Buy Now | 23.7% | Jefferies | Matthew Taylor | $103 → $107 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 21.39% | Truist Securities | Richard Newitter | $101 → $105 | Maintains | Buy | Get Alert |
| 07/19/2023 | Buy Now | 23.7% | Baird | David Rescott | → $107 | Initiates | → Outperform | Get Alert |
| 07/14/2023 | Buy Now | 17.92% | Morgan Stanley | Patrick Wood | $102 → $102 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | Buy Now | 27.17% | Citigroup | Joanne Wuensch | $101 → $110 | Maintains | Buy | Get Alert |
| 06/27/2023 | Buy Now | 9.83% | Mizuho | Anthony Petrone | → $95 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2023 | Buy Now | 17.92% | Morgan Stanley | Patrick Wood | → $102 | Assumes | → Overweight | Get Alert |
| 05/18/2023 | Buy Now | 16.76% | Truist Securities | Richard Newitter | $97 → $101 | Maintains | Buy | Get Alert |
| 05/04/2023 | Buy Now | 10.98% | RBC Capital | Shagun Singh | → $96 | Reiterates | → Outperform | Get Alert |
| 04/28/2023 | Buy Now | 17.92% | Barclays | Matt Miksic | $94 → $102 | Maintains | Overweight | Get Alert |
| 04/27/2023 | Buy Now | 16.76% | Citigroup | Joanne Wuensch | $97 → $101 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | 12.14% | Truist Securities | Richard Newitter | $93 → $97 | Maintains | Buy | Get Alert |
| 04/27/2023 | Buy Now | -4.05% | Piper Sandler | Adam Maeder | $80 → $83 | Maintains | Neutral | Get Alert |
| 04/27/2023 | Buy Now | 10.98% | RBC Capital | Shagun Singh | $95 → $96 | Maintains | Outperform | Get Alert |
| 04/27/2023 | Buy Now | 17.92% | Morgan Stanley | Cecilia Furlong | $95 → $102 | Maintains | Overweight | Get Alert |
| 04/27/2023 | Buy Now | 4.05% | Wells Fargo | Larry Biegelsen | $78 → $90 | Maintains | Equal-Weight | Get Alert |
| 04/25/2023 | Buy Now | 9.83% | Mizuho | Anthony Petrone | $85 → $95 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | 0.58% | Stifel | Rick Wise | $75 → $87 | Maintains | Hold | Get Alert |
| 04/17/2023 | Buy Now | 7.51% | Truist Securities | Richard Newitter | $86 → $93 | Maintains | Buy | Get Alert |
| 04/03/2023 | Buy Now | 12.14% | Citigroup | Joanne Wuensch | $92 → $97 | Maintains | Buy | Get Alert |
| 03/29/2023 | Buy Now | -2.89% | UBS | Danielle Antalffy | → $84 | Initiates | → Neutral | Get Alert |
| 03/08/2023 | Buy Now | -9.83% | Wells Fargo | Larry Biegelsen | $97 → $78 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/06/2023 | Buy Now | — | Raymond James | Jayson Bedford | — | Downgrade | Outperform → Market Perform | Get Alert |
| 02/01/2023 | Buy Now | -12.14% | Canaccord Genuity | William Plovanic | $68 → $76 | Maintains | Hold | Get Alert |
| 02/01/2023 | Buy Now | -0.58% | Truist Securities | Richard Newitter | $85 → $86 | Maintains | Buy | Get Alert |
| 01/30/2023 | Buy Now | -7.51% | Piper Sandler | Adam Maeder | $95 → $80 | Downgrade | Overweight → Neutral | Get Alert |
| 01/06/2023 | Buy Now | 9.83% | Morgan Stanley | Cecilia Furlong | $92 → $95 | Maintains | Overweight | Get Alert |
| 12/13/2022 | Buy Now | -4.05% | Raymond James | Jayson Bedford | $85 → $83 | Maintains | Outperform | Get Alert |
| 12/12/2022 | Buy Now | 6.36% | Citigroup | Joanne Wuensch | $99 → $92 | Maintains | Buy | Get Alert |
| 12/07/2022 | Buy Now | -1.73% | Mizuho | Anthony Petrone | $100 → $85 | Maintains | Buy | Get Alert |
| 12/06/2022 | Buy Now | -13.29% | Stifel | Rick Wise | $95 → $75 | Downgrade | Buy → Hold | Get Alert |
| 12/02/2022 | Buy Now | — | Wolfe Research | Mike Polark | — | Downgrade | Outperform → Peer Perform | Get Alert |
| 11/28/2022 | Buy Now | 21.39% | RBC Capital | Shagun Singh | $118 → $105 | Maintains | Outperform | Get Alert |
| 11/03/2022 | Buy Now | -15.61% | Goldman Sachs | Amit Hazan | $97 → $73 | Maintains | Neutral | Get Alert |
| 10/31/2022 | Buy Now | -1.73% | Raymond James | Jayson Bedford | $120 → $85 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | 13.29% | Morgan Stanley | Cecilia Furlong | $108 → $98 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 36.42% | RBC Capital | Shagun Singh | $128 → $118 | Maintains | Outperform | Get Alert |
| 10/28/2022 | Buy Now | 9.83% | Truist Securities | Richard Newitter | $112 → $95 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | 7.51% | Wells Fargo | Larry Biegelsen | $121 → $93 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 14.45% | Citigroup | Joanne Wuensch | $107 → $99 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | 9.83% | Piper Sandler | Adam Maeder | $120 → $95 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | — | Oppenheimer | Suraj Kalia | — | Downgrade | Outperform → Perform | Get Alert |
| 10/26/2022 | Buy Now | 15.61% | Mizuho | Anthony Petrone | → $100 | Initiates | → Buy | Get Alert |
| 10/18/2022 | Buy Now | 10.98% | Barclays | Matt Miksic | → $96 | Initiates | → Overweight | Get Alert |
| 10/14/2022 | Buy Now | 5.2% | Canaccord Genuity | William Plovanic | $106 → $91 | Maintains | Hold | Get Alert |
| 10/12/2022 | Buy Now | 27.17% | Jefferies | Matthew Taylor | → $110 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 24.86% | Morgan Stanley | Cecilia Furlong | $119 → $108 | Maintains | Overweight | Get Alert |
| 09/22/2022 | Buy Now | 29.48% | Truist Securities | Richard Newitter | $117 → $112 | Maintains | Buy | Get Alert |
| 07/29/2022 | Buy Now | 38.73% | Raymond James | Jayson Bedford | $124 → $120 | Maintains | Outperform | Get Alert |
| 07/29/2022 | Buy Now | 36.42% | Citigroup | Joanne Wuensch | $115 → $118 | Maintains | Buy | Get Alert |
| 07/29/2022 | Buy Now | 38.73% | Piper Sandler | Adam Maeder | $125 → $120 | Maintains | Overweight | Get Alert |
| 07/29/2022 | Buy Now | 22.54% | Canaccord Genuity | William Plovanic | $115 → $106 | Downgrade | Buy → Hold | Get Alert |
FAQ
What is the target price for Edwards Lifesciences (EW) stock?
The latest price target for Edwards Lifesciences (NYSE:EW) was reported by Truist Securities on July 16, 2024. The analyst firm set a price target for $110.00 expecting EW to rise to within 12 months (a possible 27.17% upside). 49 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Edwards Lifesciences (EW)?
The latest analyst rating for Edwards Lifesciences (NYSE:EW) was provided by Truist Securities, and Edwards Lifesciences maintained their buy rating.
When was the last upgrade for Edwards Lifesciences (EW)?
The last upgrade for Edwards Lifesciences Corp happened on May 22, 2024 when Citigroup raised their price target to $105. Citigroup previously had a neutral for Edwards Lifesciences Corp.
When was the last downgrade for Edwards Lifesciences (EW)?
The last downgrade for Edwards Lifesciences Corp happened on January 4, 2024 when Evercore ISI Group changed their price target from $80 to $77 for Edwards Lifesciences Corp.
When is the next analyst rating going to be posted or updated for Edwards Lifesciences (EW)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Edwards Lifesciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Edwards Lifesciences was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
Is the Analyst Rating Edwards Lifesciences (EW) correct?
While ratings are subjective and will change, the latest Edwards Lifesciences (EW) rating was a maintained with a price target of $105.00 to $110.00. The current price Edwards Lifesciences (EW) is trading at is $86.50, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.